Alligator Bioscience

Alligator Bioscience Equity

The The Equity of Alligator Bioscience (ATORX.ST) as of Oct 15, 2026 is 6.86 M SEK. In the previous year, The Equity was -130.59 M SEK — a change of -105.25% (higher).

Equity

6.86 MSEK

YoY

-105.25%

Last updated:

In 2025, Alligator Bioscience's equity was 6.86 M SEK, a -105.25% increase from the -130.59 M SEK equity in the previous year.

The Alligator Bioscience Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2018
468.31 M SEK
Jan 1, 2019
258.50 M SEK
Jan 1, 2020
115.24 M SEK
Jan 1, 2021
282.27 M SEK
Jan 1, 2022
89.05 M SEK
Jan 1, 2023
11.86 M SEK
Jan 1, 2024
-130.59 M SEK
Jan 1, 2025
6.86 M SEK
The Alligator Bioscience Equity history
YEAREquityYoY
6.86 MSEK-105.25%
-130.59 MSEK-1,201.54%
11.86 MSEK-86.69%
89.05 MSEK-68.45%
282.27 MSEK+144.94%
115.24 MSEK-55.42%
258.50 MSEK-44.80%
468.31 MSEK-24.22%
617.96 MSEK-8.61%
676.19 MSEK+70.34%
396.97 MSEK+479.36%
68.52 MSEK—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Alligator Bioscience Stock analysis

What does Alligator Bioscience do? Alligator Bioscience is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Alligator Bioscience's Equity

Alligator Bioscience's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Alligator Bioscience's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Alligator Bioscience's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Alligator Bioscience's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Alligator Bioscience’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Alligator Bioscience stock

The Equity of Alligator Bioscience is 6.86 M SEK in 2025.

The Equity of Alligator Bioscience changed from -130.59 M SEK to 6.86 M SEK, representing a -105.25% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Equity Alligator Bioscience since 2006 – with annual values, charts, and detailed analysis.

The Equity's SEK is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Alligator Bioscience historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — Alligator Bioscience

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Alligator Bioscience